Medpage Today on MSN9d
Year in Review: Multiple Myeloma
The drug is again under review at the FDA as a treatment for myeloma.
The new understanding of molecular events that drive the various forms of amyloidosis has generated treatment strategies that ...
Results from the company’s Phase I trial found its prodrug, SPT-300, was well tolerated, opening the doors to a Phase IIb ...
The following is a summary of “Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal ...
Belantamab Mafodotin shows significant OS benefit, reducing the risk of death by 42% in multiple myeloma at or after first ...
Anita D'Souza, MD, discusses some of the potentially practice-changing data that were presented at the 2024 ASH Annual ...
DHA Omega-3 Supplements from Canola Health Canada has Approved Nutriterra DHA Canola as an ingredient in dietary supplements ...
The rebel leader who helped oust the Assad regime calls on countries to hand over “criminals” who fled Syria. A new caretaker prime minister warns that the country faces a dire financial ...
Christopher Wray Will Step Down as F.B.I. Director President-elect Trump had already signaled his intention to replace Mr. Wray with a longtime loyalist, Kash Patel. U.S. Colleges Warn Foreign ...
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...
US Bankers Are Cautious Towards Cryptos Despite Upcoming Pro-Crypto Administration ...